Apellis Pharmaceuticals, Inc. (FRA:1JK)

Apellis Pharmaceuticals Revenue

Apellis Pharmaceuticals had revenue of $458.58M USD in the quarter ending September 30, 2025, with 132.98% growth. This brings the company's revenue in the last twelve months to $1.02B, up 42.11% year-over-year. In the year 2024, Apellis Pharmaceuticals had annual revenue of $781.37M with 97.02% growth.

• Revenue (ttm): $1.02B
• Revenue Growth: +42.11%
• P/S Ratio: 2.78
• Revenue / Employee: $1.43M
• Employees: 710
• Market Cap: 2.40B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	781.37M	384.78M	97.02%
Dec 31, 2023	396.59M	321.17M	425.83%
Dec 31, 2022	75.42M	8.86M	13.31%
Dec 31, 2021	66.56M	-184.08M	-73.44%
Dec 31, 2020	250.65M	-	-